After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Yahoo Finance discussed the stock recently as it posted Syndax to Announce Fourth Quarter and Year-end 2023 Financial Results and Host Conference Call and Webcast on February 27, 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Syndax Pharmaceuticals Inc is $1.86B. A total of 0.87 million shares were traded on the day, compared to an average of 1.52M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, SNDX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 10 BUYs and 11 SELLs from insiders. Insiders purchased 400,129 shares during that period but sold 400,706.
In the most recent transaction, Morrison Briggs sold 52,855 shares of SNDX for 18.27 per share on Aug 09. After the transaction, the Director now owns 17,836 company shares. In a previous transaction on Aug 02, Meury William sold 83,000 shares at 20.46 per share. SNDX shares that Director owns now total 48,000.
Among the insiders who sold shares, Morrison Briggs disposed of 52,855 shares on Jul 10 at a per-share price of $20.40. This resulted in the Director holding 17,836 shares of SNDX after the transaction. In another insider transaction, Goldan Keith A. sold 577 shares at $22.31 per share on Jun 13. Company shares held by the Chief Financial Officer now total 2,628.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for SNDX in the last 3 months, the mean price target is $35.25 with high estimates of $45.00 and low estimates of $23.00. In terms of 52-week highs and lows, SNDX has a high of $25.75 and a low of $11.22.
As of this writing, SNDX has an earnings estimate of -$0.99 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.84 per share and a lower estimate of -$1.15. The company reported an EPS of -$0.64 in the last quarter, which was 12.30% higher than expectations of -$0.73.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SNDX’s latest balance sheet shows that the firm has $446.83M in Cash & Short Term Investments as of fiscal 2021. There were $20.97M in debt and $20.68M in liabilities at the time. Its Book Value Per Share was $5.16, while its Total Shareholder’s Equity was $408.37M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SNDX is Buy with a score of 5.00.
